Flublok: Phase III data

An open-label, Japanese Phase III trial in 55 healthy volunteers aged >=61 years showed that intramuscular ASP7374 had "favorable immunogenicity."

Read the full 202 word article

How to gain access

Continue reading with a
two-week free trial.